Cite
MLA Citation
Brigette B. Y. Ma et al.. “Intermittent versus continuous erlotinib with concomitant modified "XELOX" (q3W) in first‐line treatment of metastatic colorectal cancer.” Cancer, vol. 119, no. 23, 2013, pp. 4145–4153. http://access.bl.uk/ark:/81055/vdc_100025044095.0x000025